INP104

COMBINATION_PRODUCT2 trials

Sponsors

Impel Pharmaceuticals

Conditions

Migraine Headache

Phase 1

Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults

CompletedNCT03401346

Impel PharmaceuticalsMigraine Headache

Start: 2017-10-19End: 2017-12-06Updated: 2019-03-15

Phase 3

Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)

CompletedNCT03557333

Impel PharmaceuticalsMigraine Headache

Start: 2018-07-13End: 2020-03-17Updated: 2021-03-11